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Summary
 
Immunostimulatory DNA and oligodeoxynucleotides containing unmethylated CpG motifs
(CpG DNA) are strongly stimulatory for B cells and antigen-presenting cells (APCs). We re-
port here that, as manifested by CD69 and B7-2 upregulation, CpG DNA also induces partial
activation of T cells, including naive-phenotype T cells, both in vivo and in vitro. Under in
vitro conditions, CpG DNA caused activation of T cells in spleen cell suspensions but failed to
stimulate highly purified T cells unless these cells were supplemented with APCs. Three lines
of evidence suggested that APC-dependent stimulation of T cells by CpG DNA was mediated
by type I interferons (IFN-I). First, T cell activation by CpG DNA was undetectable in IFN-
IR
 
2/2
 
 mice. Second, in contrast to normal T cells, the failure of purified IFN-IR
 
2/2
 
 T cells to
respond to CpG DNA could not be overcome by adding normal IFN-IR
 
1
 
 APCs. Third, IFN-I
(but not IFN-
 
g
 
) caused the same pattern of partial T cell activation as CpG DNA. Signifi-
cantly, T cell activation by IFN-I was APC independent. Thus, CpG DNA appeared to stimu-
late T cells by inducing APCs to synthesize IFN-I, which then acted directly on T cells via
IFN-IR. Functional studies suggested that activation of T cells by IFN-I was inhibitory. Thus,
exposing normal (but not IFN-IR
 
2/2
 
) T cells to CpG DNA in vivo led to reduced T prolifer-
ative responses after TCR ligation in vitro.
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C
 
pG DNA (nonvertebrate DNA and synthetic oligo-
deoxynucleotides [ODNs]
 
1
 
 containing unmethylated
CpG motifs) has been shown to cause strong activation of
B cells, NK cells, macrophages, and dendritic cells (1–7).
Although activation of NK cells is thought to be mediated
by cytokines produced by activated macrophages, i.e., IL-
12 or IL-18 (8), the effect of CpG DNA on both B cells
and macrophages appears to be direct (3, 6). Thus, CpG
DNA can stimulate highly purified normal B cells and mac-
rophages as well as cell lines derived from these cells (3, 6,
and our unpublished data). On the other hand, several re-
cent studies have demonstrated that CpG DNA and ODNs
can function as a strong adjuvant for antigen-specific T cell
responses (9–14). However, the mechanisms involved in
the adjuvant function of CpG DNA are largely unknown.
With one exception (13), most studies have revealed no
evidence for direct T cell stimulation by CpG DNA. Nev-
ertheless, injection of CpG DNA in mice results in produc-
tion of a variety of inflammatory cytokines, including
TNF-
 
a
 
, IL-1, IL-6, and type I (
 
a
 
/
 
b
 
) IFNs (IFN-I) (6, 8,
15–17). Of these cytokines, IFN-I has pleomorphic effects
on the immune system, including activation of macro-
phages (18), stimulation of NK cells (19), and proliferation
of memory-phenotype (CD44
 
hi
 
) CD8
 
1
 
 cells (20).
In this paper, we present evidence that the activities of
CpG DNA and IFN-I are closely connected. Injecting
mice with CpG DNA or CpG ODNs causes partial activa-
tion (upregulation of CD69 and B7-2) of various cell types,
including B cells, APCs, and both naive- and memory-
phenotype T cells. Significantly, for T cells such activation
is IFN-I dependent and can be mimicked by purified IFN-I.
 
1
 
Abbreviations used in this paper:
 
 ICAM, intercellular adhesion molecule;
KO, knockout; ODNs, oligodeoxynucleotides.
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Materials and Methods
 
Mice.
 
C57BL/6J (B6), C57BL/6J-Rag-1
 
tm1Mom
 
 (Rag-1
 
2/2
 
),
C57BL/6J-bg
 
J
 
/
 
1
 
 (beige), C57BL/6-Igh-6
 
tm1Cgn
 
 (
 
m
 
MT), C3H/
HeJ, and C3H/HeOuJ mice were purchased from The Jackson
Laboratory (Bar Harbor, ME). Mice lacking both class I (
 
b
 
2 mi-
croglobulin) and class II MHC molecules (MHC I
 
2
 
II
 
2
 
 mice)
were provided by Dr. C. Surh at The Scripps Research Institute
(TSRI). 129/SvEvTacfBR (129) mice were purchased from
Taconic Farms (Germantown, NY). 129 background mice defec-
tive in IFN-
 
a
 
/
 
b
 
 receptor function (IFN-IR
 
2/2
 
 mice) (21) were
originally purchased from B&K Universal (North Humberside,
UK) and were maintained and bred in the animal facility at
TSRI.
 
Antibodies and Other Reagents.
 
The following mAbs were
used: 3.168.8 (anti-CD8); RL172 (anti-CD4); J11d (anti–heat
stable antigen); J1j.10 (anti–Thy-1.2; as described in reference 4).
Conjugated antibodies (PE–anti-CD8
 
a
 
, PE–anti-CD8
 
b
 
, PE–
anti-CD4, PE–anti-B220, FITC–anti-CD69, FITC–anti-B7-2,
FITC–anti-CD25, FITC–anti-intercellular adhesion molecule
(ICAM)-1, and FITC–anti-Ly-6C) were purchased from Phar-
Mingen (San Diego, CA). FITC–anti-K
 
b
 
 mAb was purchased
from Caltag Labs. (Burlingame, CA). Biotin–anti-CD44 (pgp-1)
mAbs were prepared by standard techniques. Cy-5–anti-CD4
(GK1.5) and Cy-5–anti-CD8 (YTS.169) were prepared using a
kit from Amersham Pharmacia Biotech (Arlington Heights, IL).
Streptavidin-Red 670 and Streptavidin-FITC was purchased
from GIBCO BRL (Gaithersburg, MD). LPS was purchased
from CalBiochem (La Jolla, CA). Recombinant mouse IFN-
 
b
 
and IFN-
 
g
 
 were purchased from Access Biomolecules (La Jolla,
CA) and R&D Systems, Inc. (Minneapolis, MN), respectively.
 
DNA and ODNs.
 
DNA from the 
 
Drosophila melanogaster
 
 cell
line, SC2, was prepared as previously described (4). DNA was
used without denaturation. CpG (GCATGACGTTGAGCT)
and ZpG (GCATGAZGTTGAGCT, Z
 
 5 
 
5
 
9
 
-methyl-C) phos-
phorothioate ODNs were designed using published sequences (3)
with modification. The ODNs were synthesized and purified us-
ing HPLC by Research Genetics, Inc. (Huntsville, AL). Residual
LPS in DNA preparations was measured using a Limulus Ame-
bocyte Lysate QCL-1000 kit from BioWhittaker (Walkersville,
MD). 
 
D
 
.
 
 melanogaster
 
 DNA preparations contained 0–10 pg of
LPS/mg of DNA.
 
Medium.
 
For proliferation assays, RPMI 1640 (GIBCO
BRL) was supplemented with 10% FCS (Irvine Scientific Co.,
Santa Ana, CA), 5% NCTC 109, 2 mM glutamine, 5 
 
3 
 
10
 
2
 
5
 
 M
2-mercaptoethanol, and antibiotics.
 
Cell Purification.
 
T cells were depleted from spleen or LN cell
suspensions by incubation with a mixture of mAbs specific for
Thy1, CD4, and CD8 plus complement for 45 min at 37
 
8
 
C; B
cells were depleted using J11d mAb plus C. CD4
 
1
 
 or CD8
 
1
 
 cells
were purified by first depleting B and CD8
 
1
 
 or CD4
 
1
 
 cells by in-
cubation with mAbs plus C followed by positive panning on
plates coated with anti-CD4 or anti-CD8 mAbs. To obtain
highly purified resting naive CD8
 
1
 
 cells, CD8
 
1
 
 cells purified by
positive panning were first stained for CD8
 
b
 
 and CD44 and then
sorted by FACS
 
Ò
 
 (Becton Dickinson, San Jose, CA). The result-
ing population was 99.9% pure for CD8
 
b
 
1
 
CD44
 
lo/int
 
 cells.
 
In Vitro Cultures.
 
For cell surface staining, unseparated spleen
cells (2.5 
 
3 
 
10
 
6
 
 cells/ml), T-enriched LN (B-depleted), B-enriched
LN (T-depleted), or positively purified LN CD4
 
1
 
 or CD8
 
1
 
 cells
(10
 
6
 
 cells/ml) were cultured in a 24- or 48-well plate overnight
in the presence of DNA or rIFNs. In reconstitution cultures, pu-
rified CD4
 
1
 
 or CD8
 
1
 
 cells were supplemented with Rag-1
 
2/2
 
spleen cells. For proliferation assays, CD8
 
1
 
 cells were purified
from LN by panning after mAb plus C treatment. Transfected
 
Drosophila
 
 APCs were prepared as previously described (4). For
stimulating proliferation of CD8
 
1
 
 cells from 129 or IFN-IR
knockout (KO) mice, purified anti-TCR (1 
 
m
 
g/ml) and anti-
CD28 (10 
 
m
 
g/ml) (PharMingen) mAbs were used to coat 96-
well plates overnight at 4
 
8
 
C. Cell proliferation was assessed by
measuring [
 
3
 
H]thymidine incorporation after adding 1 
 
m
 
Ci
[
 
3
 
H]thymidine for 8 h to the cultures. The data shown in the fig-
ures are means of either duplicate or triplicate cultures.
 
In Vivo Activation of B and T Cells by DNA.
 
B6, 129, or IFN-IR
KO mice were injected subcutaneously in the lower hind limbs
with either PBS, 
 
D
 
.
 
 melanogaster
 
 DNA (100 
 
m
 
g/mouse), or
ODNs (50 
 
m
 
g/mouse) overnight. Draining (popliteal) LN and
nondraining (mesenteric) LN cells were harvested 18 h later and
stained.
 
Cell Surface Staining and Flow Cytometry.
 
Cultured cells were
first depleted of dead cells and debris by Ficoll-gradient centrifu-
gation (Sigma Chemical Co., St. Louis, MO). Staining for cell
surface markers was done essentially as previously described (4).
When staining unseparated spleen or LN cells, four-color staining
was usually performed, which involved initial staining with Cy-
5–anti-CD4 (or CD8), PE–anti-B220, biotin–anti-CD44, and
FITC–CD69 (or B7-2, K
 
b
 
, ICAM-1, Ly-6C, or CD25) followed
by washing and staining with streptavidin–Red-670. For two-
color staining, propidium iodide was also included at a concen-
tration of 1 
 
m
 
g/ml. Live cells (propidium iodide–negative) were
acquired and analyzed on a FACScan
 
Ò
 
 or FACsort
 
Ò
 
 flow cyto-
meter.
 
Results
 
Upregulation of CD69 Expression on T Cell Subsets by CpG
DNA.
 
We and others have shown that nonvertebrate
DNA and synthetic ODNs containing unmethylated CpG
motifs act as a strong B cell mitogen in vitro and elicit cy-
tokine production by APC (1, 3, 4, 6, 8, 15–17). To inves-
tigate whether CpG DNA is capable of causing T cell acti-
vation, normal B6 mice were injected subcutaneously with
insect DNA or synthetic ODNs; the two ODNs used con-
tained a single CpG motif and were identical except that
the C in the CpG motif was unmethylated for one ODN
(CpG ODN) but methylated for the other (ZpG ODN).
For insect DNA, we have shown previously that selective
CpG methylation greatly reduced the capacity of DNA to
cause B cell proliferation (4), indicating that, as for other
nonvertebrate DNA, the mitogenic properties of insect
DNA are controlled largely by unmethylated CpG motifs.
To examine T cell activation, draining LN cells from the
injected mice were stained for upregulation of CD69 at 18 h
after injection. As expected, both insect DNA and CpG
(but not ZpG) ODNs induced strong CD69 upregulation
on B cells (data not shown). Surprisingly, however, CD69
upregulation was also apparent on LN CD4
 
1
 
 and CD8
 
1
 
cells, both on naive-phenotype (CD44
 
lo/int
 
) and memory-
phenotype (CD44
 
hi
 
) cells (Fig. 1 
 
A
 
). Essentially similar
findings applied when spleen cells were cultured overnight
with insect DNA or ODNs in vitro (Fig. 1 
 
B
 
).
Titrating the concentration of DNA/ODNs added to
spleen cell cultures showed that CD69 upregulation was 
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more marked on B (B220
 
1
 
) cells than on T cells and was
more apparent on CD8
 
1
 
 cells than on CD4
 
1
 
 cells (Fig. 1,
 
B
 
 and 
 
C
 
). For both CD4
 
1
 
 and CD8
 
1
 
 cells, CD69 upregu-
lation was most noticeable on memory CD44
 
hi
 
 cells, but
was clearly apparent on naive CD44
 
lo/int
 
 cells (Fig. 1, 
 
B
 
 and
 
D
 
). Unlike insect DNA and CpG ODNs, ZpG ODNs
caused only minimal activation of B cells and no detectable
activation of T cells (Fig. 1, 
 
B
 
 and 
 
C
 
).
In previous studies, CD69 upregulation on naive T cells
was found after injecting mice with LPS (22), which raised
the possibility that the stimulatory properties of DNA and
ODNs reflected contamination with LPS. This possibility is
unlikely because, with both insect DNA (Fig. 2 
 
A
 
) and
CpG ODNs (data not shown), upregulation of CD69 on
splenic CD8
 
1
 
 cells in vitro applied equally to LPS-nonre-
sponder C3H/HeJ and LPS-responder C3H/HeOuJ spleen;
by contrast, adding LPS to spleen cells induced T cell
CD69 upregulation only on C3H/HeOuJ and not C3H/
HeJ spleen cells (Fig. 2 
 
A
 
). DNA-induced CD69 upregula-
tion on T cells was also found for spleen cells taken from B
cell–deficient 
 
m
 
MT and NK-deficient beige mice (Fig. 2, 
 
B
 
and 
 
C), suggesting that neither B cells nor NK cells were
required for the stimulatory activity of DNA.
Role of APCs. The above in vitro data apply to T cells
in suspensions of spleen, an organ rich in APC. Signifi-
cantly, addition of insect DNA or CpG ODNs to highly
purified LN T cells in vitro caused only minimal CD69 up-
regulation both for CD41 and CD81 T cells (Fig. 3).
However, strong CD69 upregulation on T cells occurred
when purified LN T cells were supplemented with T and
B cell–deficient APCs, e.g., spleen cells from Rag-12/2
(Rag-1 KO) mice (Fig. 3 A). This effect of APCs did not
require T cell recognition of MHC molecules because sim-
ilar findings occurred with APCs prepared from combined
MHC I2/2II2/2 (MHC KO) mice (Fig. 3 B). The capacity
of APCs to restore DNA-induced upregulation of CD69
Figure 1. CD69 upregulation on T cells in response to insect DNA
and synthetic ODNs. (A) B6 mice were injected subcutaneously with 100
mg/mouse D. melanogaster DNA or 50 mg/mouse ODNs. Draining LN
cells were removed 18 h later and double-stained for CD4 or CD8 and
also for CD44 and CD69 expression. (B) 5 3 106 unseparated spleen
cells/ml were cultured in vitro in the presence of D. melanogaster DNA
(100 mg/ml) or ODNs (1 mM) overnight. Cells were then harvested, pu-
rified with Ficoll gradients, and stained for CD4 or CD8, CD44, and
CD69 expression. For C and D, see B, except that spleen cells were cul-
tured with various concentrations of D. melanogaster DNA or ODNs.
Figure 2. DNA-induced upregulation of CD69 on spleen CD81 cells
from LPS-nonresponder, mMT, and beige mice. As in Fig. 1 B, spleen
cells from C3H/HeJ versus C3H/HeOuJ mice (A), B6 versus mMT mice
(B), or B6 versus beige mice (C) were cultured overnight with D. melano-
gaster DNA (100 mg/ml) or LPS (1 mg/ml) and then stained for CD8 and
CD69 expression. The data show the percentage of CD81 cells that were
positive for CD69 relative to unstimulated CD81 cells.
Figure 3. DNA-induced upregulation of CD69 on T cells requires
APCs. Purified CD41 or CD81 cells (106 cells/well) were cultured over-
night in the presence or absence of D. melanogaster DNA (100 mg/ml), ei-
ther alone or in the presence of RAG-12/2 spleen cells (A) or B cell–
depleted spleen cells from MHC I2/2II2/2 mice (panel B; B2 MHC KO
spl.); spleen APCs were added at 2 3 106 cells/well. In C, purified CD81
CD44lo/int cells (106 cells/well) 6 DNA were cultured overnight with ti-
trated numbers of RAG-1 KO spleen cells. For A–C, cells were stained
for CD8 and CD69 expression. The data show the percentage of gated
CD81 cells that were positive for CD69 expression relative to unstimu-
lated CD81 cells.2338 Type I IFN-mediated Stimulation of T Cells by CpG DNA
on T cells was not restricted to memory-phenotype T cells
because similar findings applied when Rag-12/2 APCs
were added to highly purified CD44lo/int cells (tested only
for CD81 cells; Fig. 3 C). Thus, the above findings indicate
that CpG DNA-induced CD69 upregulation on T cells is
APC dependent but MHC independent.
Upregulation of Other Cell Surface Molecules on T Cells and
the Role of IFN-I. DNA-induced activation of T cells in
the presence of APCs was manifested not only by CD69
upregulation but also by significant upregulation of several
other cell surface molecules, including B7-2, class I (Kb),
Ly-6C, and ICAM-1; expression of certain other mole-
cules, such as CD25 (IL-2Ra) and B7-1, remained un-
changed (Fig. 4 A and data not shown). Under in vivo
conditions, these surface marker changes were induced by
injection of either insect DNA (Fig. 4 A) or CpG ODNs
(data not shown) and affected B as well as T cells. Upregu-
lation of surface markers was prominent for B6 mice (Fig.
4 A) but was also apparent at a lower level for 129 mice
(Fig. 4 B; note the difference in scales for A and B). As
illustrated for 129 mice, DNA-induced upregulation of
multiple surface markers on T cells was also apparent in
vitro, e.g., when insect DNA was added to purified T cells
(CD81 cells) supplemented with APC (Fig. 4 C).
Of the above cell surface molecules upregulated by
DNA, one of the markers, Ly-6C, is known to be upregu-
lated by IFN-I (23). For this reason, it seemed possible that
the T cell–activating properties of DNA were mediated
largely or partly through production of IFN-I by APC.
This possibility was examined by injecting insect DNA into
IFN-IR2/2 mice on a 129 background versus wild-type
129 mice as controls. The striking finding was that, for all
of the cell surface markers studied, upregulation of these
markers after DNA injection was virtually undetectable in
IFN-IR2/2 mice but clearly apparent in the control 129
mice (Fig. 4 B). Except for ICAM-1 (see below), essentially
identical findings applied when DNA was added in vitro to
purified populations of IFN-IR2/2 versus 129 T cells
(CD81 cells) supplemented with normal IFN-IR1/1 APCs,
i.e., Rag-12/2 spleen cells (Fig. 4 C). Since these APCs
were ineffective with IFN-IR2/2 T cells, the data indicate
that DNA-induced T cell activation is (a) IFN-I dependent
and (b) requires IFN-IR expression at the T cell level.
Therefore, the implication is that DNA stimulates APC to
produce IFN-I, which then activates T cells via IFN-IR.
T and B Cell Activation by IFN-I. The notion that DNA
causes T cell activation through production of IFN-I by
APCs suggests that IFN-I can induce direct activation of T
cells without a requirement for APCs. In support of this pre-
diction, culturing purified B cells (Fig. 5, left) or T cells
(CD81 cells; Fig. 5, right) with graded concentrations of
IFN-I (IFN-b) overnight caused much the same pattern of
cell surface marker upregulation as was seen above with insect
DNA; expression of other markers (B7-1, CD25) remained
unchanged (data not shown). With addition of IFN-g, by
contrast, upregulation of surface markers was restricted to
ICAM-1 on T cells and to B7-2, Kb and ICAM-1 on B cells.
It should be noted that only IFN-g and not IFN-I caused
ICAM-1 upregulation on purified B cells, which suggests
that the upregulation of ICAM-1 on B cells induced after
DNA injection (Fig. 4) may have been mediated by IFN-g
rather than IFN-I; if so, the lack of ICAM-1 upregulation on
IFN-IR2/2 B cells after DNA injection (Fig. 4 B) implies
that IFN-g production in vivo may be IFN-I dependent. In
contrast to B cells, both IFN-g and IFN-I induced ICAM-1
upregulation on T cells (Fig. 5). Interestingly, for several
molecules, notably CD69 and B7-2, IFN-g potentiated the
stimulatory properties of IFN-I (data not shown).
These data applied to purified T and B cells. Essentially
similar findings applied when unseparated spleen cells were
cultured overnight in vitro with IFN-I (data not shown).
In this situation, upregulation of the above markers (and
also B7-1) was apparent on dendritic cells, i.e., on CD11c
(N418)1 (24) cells.
Influence of IFN-I on T Proliferative Responses. As discussed
above, exposing T cells to IFN-I induced partial activation
Figure 4. DNA-induced upregulation of various cell surface molecules
on lymphoid subsets from normal versus IFN-IR2/2 mice. (A and B) Nor-
mal B6 mice (A) or 129 versus IFN-IR2/2 mice (B) were injected subcuta-
neously with D. melanogaster DNA (100 mg/mouse); 18 h later, draining
LN cells were double-stained for expression of the markers shown and also
for B220, CD4, and CD8 expression. The data are expressed as the per-
centage increase in the mean fluorescence intensity of staining for cells from
DNA-injected mice versus PBS-injected mice. In C, purified CD81 cells
from 129 or IFN-IR2/2 mice (106 cells/well) were cultured in vitro with or
without D. melanogaster DNA (100 mg/ml), either alone or with RAG-12/2
spleen APCs (2 3 106 cells/well), and then stained for CD8 and the mark-
ers shown 18 h later. The data are expressed as the mean fluorescence in-
tensity of staining for the marker shown, gating on CD81 cells.2339 Sun et al.
of the cells, i.e., upregulation of B7-2 and CD69. Would
such activation alter the capacity of T cells to mount T
proliferative responses? This question is of interest because
it is well established that IFN-I has an antiproliferative ef-
fect on many cell types, including T cells (25–28). To ex-
amine this issue, we studied the proliferative response of T
cells prepared from mice injected with insect DNA.
In initial experiments, normal 129 versus IFN-IR2/2
mice were injected with large doses of insect DNA and
then killed 1 d later to prepare purified LN CD81 cells.
Confirming earlier results (Fig. 4), after DNA injection
CD69 expression was high on 129 CD81 cells (.50%) but
low on IFN-IR2/2CD81 cells (,5%), indicating that only
129 CD81 cells were activated after DNA injection. Prolif-
erative responses of purified CD81 cells after culture for 2
or 3 d in wells coated with a mixture of anti-TCR and
anti-CD28 mAbs are shown in Fig. 6 A. As expected, pro-
liferative responses of IFN-IR2/2 CD81 cells to TCR/
CD28 ligation were as high with cells from DNA-injected
mice as with cells from PBS-injected controls. By contrast,
with CD81 cells from 129 mice, proliferative responses
were considerably reduced (by about twofold) with cells
from DNA-injected mice relative to PBS-injected mice.
Similar findings applied to the proliferative response of
CD81 2C TCR transgenic cells. As described previously
(4), 2C CD81 cells on a B6 (Kb) background respond
strongly to a specific peptide, QL9, presented by Ld mole-
cules on Ld-transfected Drosophila cells coexpressing B7-1
and ICAM-1 molecules. As illustrated in Fig. 6 B, purified
CD81 2C cells from control PBS-injected donors gave
strong proliferative responses to even low doses of QL9
peptide presented by transfected Drosophila cells as APCs;
with limiting doses of peptide peak responses occurred on
day 3 of culture. However, when CD81 2C cells were pre-
pared from donors injected 1 d before with insect DNA,
these CD81 cells (.50% CD691) gave poor proliferative
responses to QL9 peptide in vitro. Relative to PBS-
injected controls, the responses of 2C cells from DNA-
injected mice were reduced by three- to fourfold. It should
be noted that prior exposure to DNA in vivo did not re-
duce T cell viability, either before or after culture in vitro.
Discussion
As mentioned earlier, it is now well established that non-
vertebrate DNA and synthetic ODNs containing unmeth-
ylated CpG motifs are stimulatory for B cells and APCs.
The data in this paper extend these observations by show-
ing that CpG DNA/ODNs are also able to stimulate T
cells, including resting T cells, as manifested by induction
of CD69 expression and upregulation of several surface
markers. Significantly, however, stimulation of T cells by
CpG DNA/ODNs required the presence of APCs and ap-
peared to be mediated solely by IFN-I. Thus, in contrast to
normal T cells, T cells from IFN-IR2/2 mice could not be
activated by CpG DNA/ODNs even when supplemented
with normal (IFN-IR1/1) APCs. This finding suggested
that CpG DNA/ODNs caused T cell activation by induc-
ing APCs to release IFN-I, which then acted directly on T
cells. In support of this notion, the pattern of T cell activa-
tion induced by CpG DNA/ODNs in the presence of
APCs could be reproduced by culturing purified T cells
with IFN-I in vitro; IFN-g was ineffective.
As for T cells, stimulation of B cells in vivo by CpG
DNA/ODNs appeared to be largely under the control of
IFN-I. Thus, in contrast to normal mice, injecting CpG
DNA/ODNs into IFN-IR2/2 mice caused minimal activa-
tion of B cells. Nevertheless, under in vitro conditions we
found that culturing unseparated IFN-IR2/2 spleen cells
with high concentrations of insect DNA did cause low but
significant upregulation of CD69 and B7 on B cells and
moderately strong proliferation of these cells (our unpub-
lished data). B cell stimulation in this situation might be
controlled by low-level IFN-I–independent production of
IFN-g because, like IFN-I, even small amounts of IFN-g
added to B cells in vitro caused upregulation of B7-2 (al-
though not CD69) (Fig. 5). Alternatively, CpG DNA/
ODNs may be directly stimulatory for B cells (3, 5). Stud-
ies with purified B cells from combined IFN-IR2/2IFN-
g2/2 mice will be needed to assess this possibility.
In the case of T cells, we have found that, as with LPS and
Poly I:C (20, 22), injecting mice with CpG DNA/ODNs
induces selective proliferation of memory-phenotype CD44hi
CD81 cells (our unpublished data); such proliferation can
also be induced by injecting various cytokines, including
IFN-g and IFN-I. For IFN-I, it is important to emphasize
that proliferation of memory-phenotype T cells in vivo
does not reflect a direct action of IFN-I on T cells but, in-
stead, stimulation of secondary cytokines, perhaps IL-15,
by APCs (29). The activity of IFN-I on naive T cells that is
Figure 5. Expression of vari-
ous cell surface markers on puri-
fied B (B2201) and CD81 cells
after incubation in vitro with
IFN-I or IFN-g. Cells (2 3 106/
well) were cultured with titrated
concentrations of IFN-I (IFN-b)
or IFN-g overnight and then
double-stained for B220 or
CD8 and the markers shown.2340 Type I IFN-mediated Stimulation of T Cells by CpG DNA
described here is quite different. With naive T cells, IFN-I
acts directly on the cells, apparently by binding to IFN-IR,
and induces a form of partial activation associated with up-
regulation of CD69 and B7. However, such activation is
not associated with entry into cell cycle (29).
It is of interest that the partial activation of T cells in-
duced by IFN-I had an inhibitory effect on T cell function.
Thus, in accordance with the evidence that IFN-I has an
antiproliferative function (25–28), exposing T cells to CpG
DNA for 1 d in vivo before TCR ligation in vitro led to a
marked reduction in T proliferative responses; this effect
was not seen with IFN-IR2/2 T cells, implying a direct in-
hibitory effect by IFN-I on T cells. Indeed, in more recent
studies we have observed that adding IFN-I to purified T
cells in vitro has a comparable antiproliferative effect (our
unpublished data). It is important to emphasize that this an-
tiproliferative effect of IFN-I is only apparent when T cells
are stimulated in the absence of viable APCs. Thus, when
normal APCs are present, IFN-I has the opposite effect and
considerably augments the T proliferative response, pre-
sumably by stimulating APCs to upregulate costimulatory
molecules; this effect is not seen with Drosophila APCs,
which are nonviable at 378C and refractory to IFN-I.
Hence, under in vivo conditions where APCs are preva-
lent, the antiproliferative function of IFN-I on T cells is
presumably countered by an adjuvant-like effect of IFN-I
on APCs. This scenario is supported by the finding that
CpG DNA/ODNs (9–14) and IFN-I–inducing agents such
as Poly I:C (20) act as powerful adjuvants for antigen-spe-
cific responses in vivo.
In summary, the data in this paper document that inject-
ing mice with CpG DNA causes strong upregulation of
activation markers on naive T cells. Such activation of T cells
is not mediated by CpG DNA per se, however, but by
IFN-I released via CpG DNA-induced stimulation of
APCs. The functional consequences of partial T cell activa-
tion induced by IFN-I are complex and will be the topic of
a future publication.
Figure 6. Prior exposure to Drosophila DNA in vivo inhibits proliferation of CD81 cells in vitro. CD81 cells were purified from the LNs of the indi-
cated mice 18 h after injection of either PBS or D. melanogaster DNA (200 mg/mouse for 2C mice, 500 mg/mouse for 129 or IFN-IR KO mice). (A) Pu-
rified CD81 cells from 129 or IFN-IR KO mice were cultured for 2 or 3 d in 200 ml wells precoated with a mixture of anti-TCR and anti-CD28 mAbs.
The data show means and SDs of duplicate cultures. (B) Purified 2C CD81 cells (2.5 3 104 cells/well) were cultured with Drosophila APCs (Ld/B7.1/
ICAM-1) and a titrated dose of QL9 peptide for the periods shown. Drosophila APCs were used at 2 3 105 cells/well. The data show means and SDs of
triplicate cultures; for many of the data points, SDs were too small to be illustrated.
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